strain 229e Search Results


hcov 229e  (ATCC)
96
ATCC hcov 229e
Hcov 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/strain+229e/pmc12828524-38-0-2?v=ATCC
Average 96 stars, based on 1 article reviews
hcov 229e - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
cov strain  (ZeptoMetrix corporation)
90
ZeptoMetrix corporation cov strain
Cov Strain, supplied by ZeptoMetrix corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/strain+229e/10__1007_slash_s13206___021___00019___y-85-7-14?v=ZeptoMetrix+corporation
Average 90 stars, based on 1 article reviews
cov strain - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hcov 229e rna levels  (ATCC)
92
ATCC hcov 229e rna levels
Detection of a 548-nucleotide deletion in a <t>HCoV</t> <t>229E</t> strain associated with myeloablation. a Depiction of the case history surrounding myeloablation and coronavirus infection. A woman in her 40s with AML was found to be infected with a <t>HCoV</t> <t>229E</t> just before her HCT. Due to the patient’s advanced disease, the decision was made to continue with the transplant. Four successive HCoV-positive nasal swab specimens were available from the patient; two from before treatment with myeloablative cyclophosphamide and total body irradiation and two from after. All days are reported relative to HCT. b Coverage plots of mNGS reads mapped to the reference genome for HCoV 229E (NC_002645) of three samples from the patient revealed the generation of a 548-nucleotide deletion in the ORF4a/4b gene. In addition to deleting 83% of the coding region from ORF4a/4b, the deletion resulted in a frame shift that resulted in a premature stop codon 10 amino acids before the reference genome stop codon. Primer binding sites are denoted in blue for confirmatory junction RT-PCR. c Confirmatory junction RT-PCR of the four available HCoV-positive nasal swabs revealed the absence of the deletion before myeloablation and the presence of the deletion in specimens taken after myeloablation. NTC , no template control
Hcov 229e Rna Levels, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/strain+229e/pmc05677986-48-13-38?v=ATCC
Average 92 stars, based on 1 article reviews
hcov 229e rna levels - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
coronaviruses 229e  (ATCC)
93
ATCC coronaviruses 229e
Detection of a 548-nucleotide deletion in a <t>HCoV</t> <t>229E</t> strain associated with myeloablation. a Depiction of the case history surrounding myeloablation and coronavirus infection. A woman in her 40s with AML was found to be infected with a <t>HCoV</t> <t>229E</t> just before her HCT. Due to the patient’s advanced disease, the decision was made to continue with the transplant. Four successive HCoV-positive nasal swab specimens were available from the patient; two from before treatment with myeloablative cyclophosphamide and total body irradiation and two from after. All days are reported relative to HCT. b Coverage plots of mNGS reads mapped to the reference genome for HCoV 229E (NC_002645) of three samples from the patient revealed the generation of a 548-nucleotide deletion in the ORF4a/4b gene. In addition to deleting 83% of the coding region from ORF4a/4b, the deletion resulted in a frame shift that resulted in a premature stop codon 10 amino acids before the reference genome stop codon. Primer binding sites are denoted in blue for confirmatory junction RT-PCR. c Confirmatory junction RT-PCR of the four available HCoV-positive nasal swabs revealed the absence of the deletion before myeloablation and the presence of the deletion in specimens taken after myeloablation. NTC , no template control
Coronaviruses 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/strain+229e/pmc07444299__NIHPP2020__08__17__20177006___supplement___1-13-8-10?v=ATCC
Average 93 stars, based on 1 article reviews
coronaviruses 229e - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
ochrobactrum intermedium strain 229e  (National Centre for Cell Science)
90
National Centre for Cell Science ochrobactrum intermedium strain 229e
Detection of a 548-nucleotide deletion in a <t>HCoV</t> <t>229E</t> strain associated with myeloablation. a Depiction of the case history surrounding myeloablation and coronavirus infection. A woman in her 40s with AML was found to be infected with a <t>HCoV</t> <t>229E</t> just before her HCT. Due to the patient’s advanced disease, the decision was made to continue with the transplant. Four successive HCoV-positive nasal swab specimens were available from the patient; two from before treatment with myeloablative cyclophosphamide and total body irradiation and two from after. All days are reported relative to HCT. b Coverage plots of mNGS reads mapped to the reference genome for HCoV 229E (NC_002645) of three samples from the patient revealed the generation of a 548-nucleotide deletion in the ORF4a/4b gene. In addition to deleting 83% of the coding region from ORF4a/4b, the deletion resulted in a frame shift that resulted in a premature stop codon 10 amino acids before the reference genome stop codon. Primer binding sites are denoted in blue for confirmatory junction RT-PCR. c Confirmatory junction RT-PCR of the four available HCoV-positive nasal swabs revealed the absence of the deletion before myeloablation and the presence of the deletion in specimens taken after myeloablation. NTC , no template control
Ochrobactrum Intermedium Strain 229e, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/strain+229e/pm25312622-0-8-36?v=National+Centre+for+Cell+Science
Average 90 stars, based on 1 article reviews
ochrobactrum intermedium strain 229e - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
coronavirus strain: 229e lysate  (ZeptoMetrix corporation)
N/A
Please consult your institution’s regulations regarding the use of this product. For a detailed discussion on biological safety see the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), published by the CDC.
   Buy from Supplier

Image Search Results


Detection of a 548-nucleotide deletion in a HCoV 229E strain associated with myeloablation. a Depiction of the case history surrounding myeloablation and coronavirus infection. A woman in her 40s with AML was found to be infected with a HCoV 229E just before her HCT. Due to the patient’s advanced disease, the decision was made to continue with the transplant. Four successive HCoV-positive nasal swab specimens were available from the patient; two from before treatment with myeloablative cyclophosphamide and total body irradiation and two from after. All days are reported relative to HCT. b Coverage plots of mNGS reads mapped to the reference genome for HCoV 229E (NC_002645) of three samples from the patient revealed the generation of a 548-nucleotide deletion in the ORF4a/4b gene. In addition to deleting 83% of the coding region from ORF4a/4b, the deletion resulted in a frame shift that resulted in a premature stop codon 10 amino acids before the reference genome stop codon. Primer binding sites are denoted in blue for confirmatory junction RT-PCR. c Confirmatory junction RT-PCR of the four available HCoV-positive nasal swabs revealed the absence of the deletion before myeloablation and the presence of the deletion in specimens taken after myeloablation. NTC , no template control

Journal: NPJ Genomic Medicine

Article Title: Myeloablation-associated deletion of ORF4 in a human coronavirus 229E infection

doi: 10.1038/s41525-017-0033-4

Figure Lengend Snippet: Detection of a 548-nucleotide deletion in a HCoV 229E strain associated with myeloablation. a Depiction of the case history surrounding myeloablation and coronavirus infection. A woman in her 40s with AML was found to be infected with a HCoV 229E just before her HCT. Due to the patient’s advanced disease, the decision was made to continue with the transplant. Four successive HCoV-positive nasal swab specimens were available from the patient; two from before treatment with myeloablative cyclophosphamide and total body irradiation and two from after. All days are reported relative to HCT. b Coverage plots of mNGS reads mapped to the reference genome for HCoV 229E (NC_002645) of three samples from the patient revealed the generation of a 548-nucleotide deletion in the ORF4a/4b gene. In addition to deleting 83% of the coding region from ORF4a/4b, the deletion resulted in a frame shift that resulted in a premature stop codon 10 amino acids before the reference genome stop codon. Primer binding sites are denoted in blue for confirmatory junction RT-PCR. c Confirmatory junction RT-PCR of the four available HCoV-positive nasal swabs revealed the absence of the deletion before myeloablation and the presence of the deletion in specimens taken after myeloablation. NTC , no template control

Article Snippet: No CPE was visualized for any of the patient’s four clinical samples and HCoV 229E RNA levels in the culture supernatant were undetectable by qRT-PCR after inoculation, while viral growth was apparent in the positive control HCoV 229E ATCC type strain (Figure ).

Techniques: Infection, Irradiation, Binding Assay, Reverse Transcription Polymerase Chain Reaction, Control

Specimens sequenced in this study

Journal: NPJ Genomic Medicine

Article Title: Myeloablation-associated deletion of ORF4 in a human coronavirus 229E infection

doi: 10.1038/s41525-017-0033-4

Figure Lengend Snippet: Specimens sequenced in this study

Article Snippet: No CPE was visualized for any of the patient’s four clinical samples and HCoV 229E RNA levels in the culture supernatant were undetectable by qRT-PCR after inoculation, while viral growth was apparent in the positive control HCoV 229E ATCC type strain (Figure ).

Techniques: